Andaluz Health Service   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Andalusia Spain (1986)

Organization Overview

First Clinical Trial
2011
NCT03204630
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Andaluz Health Service | Juan Macías

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Coinfection (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Fatty Liver (Phase 4)

Pneumonia (Phase 3)

Pneumonia, Bacterial (Phase 3)

Pressure Ulcer (Phase 4)

Stroke (Phase 1)

Syndrome (Phase 4)

Ulcer (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 16